鼻咽癌调强放疗的回顾性剂量学研究:测量引导的三维剂量重建与分析
本研究纳入30例鼻咽癌调强放疗计划,比较传统二维模体平面剂量验证与测量引导三维剂量重建方法。结果显示二维验证通过后仍存在靶区欠量和危及器官过量风险,三维容积剂量验证更能反映临床相关剂量误差。
要点
- 二维平面剂量验证通过后仍可能存在鼻咽癌靶区欠量和危及器官过量。
- 结构特异性γ通过率在更严格标准下显著下降,包括PTV。
- 推荐测量引导三维容积剂量验证用于复杂鼻咽癌调强放疗。
核心结论
- 即使通过治疗前模体剂量验证,仍存在PTVnx欠量和关键结构过量的剂量误差风险。
- 测量引导三维容积剂量验证被推荐为复杂鼻咽癌调强放疗更临床有效的验证方法。
研究设计与样本
- 回顾性剂量学研究,分析30例鼻咽癌病例的放疗计划及其治疗前二维模体平面剂量验证数据。
- 使用3DVH软件在患者CT图像上重建三维剂量分布,并与治疗计划比较。
主要发现
- 三维剂量重建在相同标准下获得的全局γ通过率与传统二维模体平面剂量验证相似。
- 在更严格标准下,结构特异性γ通过率显著下降,包括计划靶区。
- 所有检查的剂量体积和容积剂量参数平均偏差范围为-2.93%至1.17%。
- PTVnx的V100%最大负偏差为-15.66%,脊髓D1cc正偏差为6.66%。
- 二维或三维全局γ通过率与大多数容积剂量参数偏差之间无显著相关性(Pearson系数0.8用于相关性评价)。
关键数值与推荐
- 全局和器官特异性γ通过率及每个结构的剂量体积直方图偏差被评估。
- 通过相关性分析研究γ通过率与容积剂量偏差之间的相互依赖性。
临床怎么用
- 对复杂鼻咽癌调强放疗,除二维平面剂量验证外,应考虑采用测量引导三维容积剂量验证以识别临床相关剂量误差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conventional phantom-based planar dosimetry (2D-PBD) quality assurance (QA) using gamma pass rate (GP (%)) is inadequate to reflect clinically relevant dose error in intensity-modulated radiation therapy (IMRT), owing to a lack of information regarding patient anatomy and volumetric dose distribution. This study aimed to evaluate the dose distribution accuracy of IMRT delivery for nasopharyngeal carcinoma (NPC), which passed the 2D-PBD verification, using a measurement-guided 3D dose reconstruction (3D-MGR) method. METHODS: Radiation treatment plans of 30 NPC cases and their pre-treatment 2D-PBD data were analyzed. 3D dose distribution was reconstructed on patient computed tomography (CT) images using the 3DVH software and compared to the treatment plans. Global and organ-specific dose GP (%), and dose-volume histogram (DVH) deviation of each structure was evaluated. Interdependency between GP (%) and the deviation of the volumetric dose was studied through correlation analysis. RESULTS: The 3D-MGR achieved global GP (%) similar to conventional 2D-PBD in the same criteria. However, structure-specific GP (%) significantly decreased under stricter criteria, including the planning target volume (PTV). The average deviation of all inspected dose volumes (DV) and volumetric dose (VD) parameters ranged from - 2.93% to 1.17%, with the largest negative deviation in V100% of the PTVnx of - 15.66% and positive deviation in D1cc of the spinal cord of 6.66%. There was no significant correlation between global GP (%) of 2D-PBD or 3D-MGR and the deviation of the most volumetric dosimetry parameters (DV or VD), when the Pearson's coefficient value of 0.8 was used for correlation evaluation. CONCLUSION: Even upon passing the pre-treatment phantom based dosimetric QA, there could still be risk of dose error like under-dose in PTVnx and overdose in critical structures. Measurement-guided 3D volumetric dosimetry QA is recommended as the more clinically efficient verification for the complicated NPC IMRT.
引用
- Sun WZ, Zhang DD, Peng YL, et al. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis. Radiat Oncol. 2018. PMID: 29544512. doi:10.1186/s13014-018-0993-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。